GL1X · GenesisL1 explorer

MolNFT v1 · #172102 · protein

Crystal structure of SMYD3 conjugate with piperidine-based covalent inhibitor EM127

6ZRB · Histone-lysine N-methyltransferase SMYD3: “Crystal structure of SMYD3 conjugate with piperidine-based covalent inhibitor EM127”. X-ray diffraction, 3 ligands (SAM, QON, ZN), 4 pockets (best druggability 0.78). MolNFT v1 #172102 on…

PDB
6ZRB
Type
protein
Length
425 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone-lysine N-methyltransferase SMYD3
EC
2.1.1.354
UniProt
Q9H7B4
Ligands
SAM, QON, ZN
Pockets
4 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 52% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone-lysine N-methyltransferase SMYD3 (EC 2.1.1.354)protein42552% helix, 13% strandQ9H7B4

Ligands and binding sites

  • SAM · S-adenosylmethionine · ligand · chains A
  • QON · N-[1-(2-Chloroacetyl)piperidin-4-yl]-5-cyclopropyl-1,2-oxazole-3-carboxamide · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18470.780.8181QON
21960.580.8132SAM
31390.470.7720empty
41090.440.7822empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6ZRB · Crystal structure of SMYD3 conjugate with piperidine-based covalent inhibitor EM127 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9H7B4 · AlphaFold monomer V2.0 prediction for histone-lysine N-methyltransferase SMYD3 (Q9H7B4) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.